Open access
Jul 2026
Bufothionine inhibits colorectal cancer progression via the STAT3/p53/SLC7A11 signaling axis
Bufothionine suppresses CRC by the STAT3/p53/SLC7A11 signaling axis in a manner associated with ferroptosis, suggesting its potential as a therapeutic agent for colorectal cancer.
Rui-Fang Xie, Nan Xiang, Guidan Zhou et al.
· Frontiers in Pharmacology · 0 citations